|
2025
|
Invention
|
Crystalline naloxone-dimethylformamide solvate, methods for its preparation and its use as a reag... |
|
|
Invention
|
Composition comprising nicotine, corresponding method and use. The invention relates to a composi... |
|
|
Invention
|
Method of making chemical compounds useful for the synthesis of buprenorphine. Described herein i... |
|
|
Invention
|
Chiral synthesis of nornicotine and nicotine.
The present invention relates to a method of produ... |
|
2024
|
Invention
|
Novel salts of 2-phenyl-2- (piperidin-2-yl) acetamide, solvates thereof, and methods of manufactu... |
|
|
Invention
|
Method of purifying cannabinoid components from plant extracts.
The invention provides a new and... |
|
|
Invention
|
Method of purifying cannabinoid components from plant extracts. The invention provides a new and ... |
|
|
Invention
|
Method of purifying cannabinoid components from plant extracts |
|
2023
|
Invention
|
Chiral synthesis of nornicotine and nicotine. The present invention relates to a method of produc... |
|
2022
|
Invention
|
Process for the synthesis of 1,3-dihydro-imidazo[4,5-b]pyridin-2-one and/or derivatives thereof. ... |
|
2018
|
Invention
|
Enantiomeric separation of racemic nicotine by addition of an o,o″-disubstituted tartaric acid en... |
|
|
Invention
|
Preparation of racemic nicotine by reaction of ethyl nicotinate with n-vinylpyrrolidone in the pr... |
|
|
Invention
|
Enantiomeric separation of racemic nicotine by addition of an o,o'-disubstituted tartaric acid en... |
|
|
Invention
|
Synthesis of mono-chlorinated acetophenone. The present invention relates to the improved synthes... |
|
|
Invention
|
Improved synthesis of mono-chlorinated acetophenone. The present invention relates to the improve... |
|
|
Invention
|
Synthesis of noroxymorphone. The present invention relates to the improved synthesis of noroxymor... |
|
2017
|
Invention
|
Supported metal catalyst for the production of hydrocodone and hydromorphone. The present inventi... |
|
|
Invention
|
Process for the preparation of trans-4-amino-1-cyclohexanecarboxilic acid and its derivatives. Th... |
|
2016
|
Invention
|
Tilidine isomerization and crystallization process. Tilidine isomerization and crystallization pr... |
|
|
Invention
|
Method of manufacturing stereoisomers of buprenorphine and analogues thereof. I represents hydrog... |
|
|
Invention
|
Method of manufacturing stereoisomers of buprenorphine and analogues thereof. The present inventi... |
|
2015
|
Invention
|
Method of manufacturing buprenorphine and analogues thereof from oripavine. The invention relates... |
|
|
Invention
|
Improved method of manufacturing buprenorphine and analogues thereof from oripavine. The in... |
|
|
Invention
|
Improved method of manufacturing buprenorphine and analogues thereof from oripavine. The inventio... |
|
2014
|
Invention
|
Mesoporous dosage forms for poorly soluble drugs. The present invention is directed to a new phar... |
|
|
Invention
|
Synthesis of noroxymorphone from morphine. The present invention is directed to an improved proce... |
|
|
Invention
|
Novel synthesis of noroxymorphone from morphine. The present invention is directed to an improved... |
|
|
Invention
|
Oral pharmaceutical formulation. Described herein are oral pharmaceutical formulations comprising... |
|
|
Invention
|
Oral pharmaceutical formulation. The present invention relates to oral pharmaceutical formulation... |
|
2013
|
Invention
|
Method for the preparation of 1-aryl-1-alkyl-2-alkyl-3-dialkylaminopropane compounds.
The presen... |
|
|
Invention
|
Method for the preparation of 1-aryl-1-alkyl-2-alkyl-3-dialkylaminopropane compounds. The present... |
|
|
Invention
|
Improved method of preparing oxymorphone. The invention relates to an improved method of preparin... |
|
2012
|
Invention
|
Process for the purification of 2,6-diisopropyl phenol. The present invention relates to a novel ... |
|
2011
|
Invention
|
Preparation of low impurity opiates in a continuous flow reactor. The present invention relates t... |
|
2008
|
Invention
|
Demethylation of 14-hydroxy substituted alkaloid derivatives. The present invention is directed t... |
|
1993
|
Invention
|
Dosage forms having prolonged active ingredient release.
Abstract
Pharmaceu... |
|
1986
|
Invention
|
Coronary therapeutic agent in the form of soft gelatin capsules. The present invention relates to... |
